Ovulatory and Metabolic Effects of d-<i>Chiro</i>-Inositol in the Polycystic Ovary Syndrome
New England Journal of MedicinePublished 29 April 1999Open access
John E. Nestler, Daniela Jakubowicz, Paula Reamer, Ronald D. Gunn, Geoffrey Allan
Citations513
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
It is hypothesized that the administration of d-chiro-inositol would replenish stores of the mediator and improve insulin sensitivity in 44 obese women with the polycystic ovary syndrome.
Abstract
D-Chiro-inositol increases the action of insulin in patients with the polycystic ovary syndrome, thereby improving ovulatory function and decreasing serum androgen concentrations, blood pressure, and plasma triglyceride concentrations.
Keywords
Medicine
DiabetesRole of Insulin Resistance in Human Disease
12,152 Citations1988Gerald M. Reaven
The possibility is raised that resistance to insulin-stimulated glucose uptake and hyperinsulinemia are involved in the etiology and clinical course of three major related diseases— NIDDM, hypertension, and CAD.
New England Journal of MedicinePolycystic Ovary Syndrome
2,459 Citations1995Stephen Franks
It is now clear that the range of presenting symptoms of women with polycystic ovaries includes not only nonhirsute women with oligomenorrhoea or amenorrhOEa but also hirsute subjects with regular, ovulatory cycles.
DiabetesProfound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
1,860 Citations1989Andrea Dunaif, Karen R. Segal +2 more
New England Journal of MedicineInsulin Resistance and Insulin Secretory Dysfunction as Precursors of Non-Insulin-Dependent Diabetes Mellitus: Prospective Studies of Pima Indians
1,500 Citations1993Stephen Lillioja, David M. Mott +7 more
Obesity, insulin resistance, and low acute plasma insulin response to intravenous glucose (with the degree of obesity and insulin resistance taken into account) were predictors of NIDDM.
Diabetes CarePrevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
1,263 Citations1999David A. Ehrmann, Randall B. Barnes +3 more
It is concluded that women with PCOS should periodically have an OGTT and must be closely monitored for deterioration in glucose tolerance, particularly among those with IGT, the subgroup at highest risk for subsequent development of NIDDM.
Journal of Steroid BiochemistryCalculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature
1,090 Citations1982R. Södergård, Torbjörn Bäckström +2 more
A mathematical model for the calculation of free and protein bound concentrations of testosterone and estradiol in plasma is presented and it was concluded that the androgen metabolites could be omitted from the calculations without affecting the calculated concentrations.
Annals of Internal MedicineSlow Glucose Removal Rate and Hyperinsulinemia Precede the Development of Type II Diabetes in the Offspring of Diabetic Parents
1,059 Citations1990James H. Warram, Blaise C. Martin +3 more
In multivariate analysis, low Kg and high serum insulin levels independently increased the risk for developing diabetes among the offspring of diabetic parents, suggesting that the primary defect is in peripheral tissue response to insulin and glucose, not in the pancreatic beta cell.
MetabolismMetformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
874 Citations1994Elsy Velázquez, Soaira Mendoza +3 more
Using polycystic ovary syndrome as a model of insulin resistance and hyperandrogenism, the effect of Metformin on lipoproteins, sex hormones, gonadotropins, and blood pressure in 26 women with PCOS was assessed.
New England Journal of MedicineEarly Metabolic Defects in Persons at Increased Risk for Non-Insulin-Dependent Diabetes Mellitus
822 Citations1989Johan G. Eriksson, A. Franssila-Kallunki +5 more
It is concluded that impaired glucose metabolism is common in the first-degree relatives of patients with NIDDM, despite their normal results on oral glucose-tolerance tests.
New England Journal of MedicineEffects of Metformin on Spontaneous and Clomiphene-Induced Ovulation in the Polycystic Ovary Syndrome
789 Citations1998John E. Nestler, Daniela Jakubowicz +2 more
The ovulatory response to clomiphene can be increased in obese women with the polycystic ovary syndrome by decreasing insulin secretion with metformin.
New England Journal of MedicineRisk Factors for Coronary Artery Disease in Healthy Persons with Hyperinsulinemia and Normal Glucose Tolerance
782 Citations1989Ivana Zavaroni, Enzo Bonora +9 more
It is concluded that healthy persons with hyperinsulinemia and normal glucose tolerance have an increase in risk factors for coronary artery disease, as compared with a well-matched group of healthy subjects with normal insulin levels.
New England Journal of MedicineDecreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary Syndrome
750 Citations1996John E. Nestler, Daniela Jakubowicz
In obese women with the polycystic ovary syndrome, decreasing serum insulin concentrations with metformin reduces ovarian cytochrome P450c17 alpha activity and ameliorates hyperandrogenism.
The Journal of Clinical Endocrinology & MetabolismA Fasting Glucose to Insulin Ratio Is a Useful Measure of Insulin Sensitivity in Women with Polycystic Ovary Syndrome<sup>1</sup>
672 Citations1998Richard S. Legro, Diane T. Finegood +1 more
A fasting G:I ratio may be useful as a screening test for insulin resistance in obese non-Hispanic white PCOS women and may be a clinically useful parameter for selecting women most likely to respond to therapeutic interventions that improve insulin sensitivity.
The Journal of Clinical Endocrinology & MetabolismCharacterization of Groups of Hyperaiidrogenic Women with Acanthosis Nigricans, Impaired Glucose Tolerance, and/or Hyperinsulinemia*
586 Citations1987Andrea Dunaif, MAGARET GRAF +3 more
It is suggested that only women with PCO have hyperinsulinemia independent of obesity; hyperinsulainemia is not a feature of hyperandrogenic states in general; and only obese PCO women are at risk for impairment of glucose tolerance, independent of the presence of AN.
Acta Obstetricia Et Gynecologica ScandinavicaPolycystic ovary syndrome and risk for myocardial infarction: Evaluated from a risk factor model based on a prospective population study of women
551 Citations1992Eva Dahlgren, P. O. Janson +3 more
In order to estimate whether women with polycystic ovary syndrome (PCOS) have an increased risk of developing myocardial infdrction, a risk factor model was applied on 33 women with PCOS and 132 age matched referents.
International Journal of Gynecology & ObstetricsWomen with polycystic ovary syndrome wedge resected in 1956 to 1965: A long-term follow-up focusing on natural history and circulating hormones
528 Citations1992Eva Dahlgren, S. Johansson +7 more
Perimenopausal women with PCOS have an increased morbidity in hypertension and diabetes mellitus that adds to the classic symptoms, such as anovulation, hirsutism and infertility.
The Journal of Clinical Endocrinology & MetabolismThe insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.
527 Citations1996Andrea Dunaif, Daniel J. Scott +3 more
troglitazone improves total body insulin action in PCOS, resulting in lower circulating insulin levels; 2) insulin resistance, probably via hyperinsulinemia, results in a general augmentation of steroidogenesis and LH release in PCos; and 3) insulin-sensitizing agents, such as trog litazone, may provide a novel therapy for PCOS.
Fertility and SterilityWomen with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones
474 Citations1992Eva Dahlgren, Saga Johansson +7 more
Perimenopausal women with PCOS have an increased morbidity in hypertension and diabetes mellitus that adds to the classic symptoms, such as anovulation, hirsutism, and infertility.
The Journal of Clinical Endocrinology & MetabolismTroglitazone Improves Defects in Insulin Action, Insulin Secretion, Ovarian Steroidogenesis, and Fibrinolysis in Women with Polycystic Ovary Syndrome<sup>1</sup>
453 Citations1997David A. Ehrmann, David J. Schneider +5 more
The ability of the beta-cell to appropriately detect and respond to an oscillatory glucose infusion improved significantly after troglitazone treatment; the normalized spectral power for the insulin secretion rate increased to 5.9 +/- 1.1 and the marked reduction in PAI-1 could be expected to improve the fibrinolytic response to thrombosis in these subjects.
Journal of Clinical InvestigationInsulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.
429 Citations1995David A. Ehrmann, Jeppe Sturis +4 more
A history of NIDDM in a first-degree relative appears to define a subset of PCOS subjects with a greater prevalence of insulin secretory defects, which may enhance the risk of developing non-insulin-dependent diabetes mellitus among women with polycystic ovary syndrome.
The Journal of Clinical Endocrinology & MetabolismLean Women with Polycystic Ovary Syndrome Respond to Insulin Reduction with Decreases in Ovarian P450c17α Activity and Serum Androgens<sup>1</sup>
368 Citations1997John E. Nestler, Daniela Jakubowicz
It is suggested that hyperinsulinemia stimulates ovarian P450c17 alpha activity in nonobese women with PCOS and decreasing serum insulin with metformin reduces ovarian cytochrome P 450c17alpha activity and ameliorates the hyperandrogenism of these women.
European Journal of EndocrinologyTherapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome
329 Citations1998Evanthia Diamanti‐Kandarakis, Chryssa Kouli +2 more
It is confirmed that metformin treatment can lead to improvements in insulin resistance and ovarian hyperandrogenism.
Obstetrics and GynecologyMenstrual Cyclicity After Metformin Therapy in Polycystic Ovary Syndrome
314 Citations1997Meriam El Aboubi, Arnaldo Acosta +1 more
A 6-month course of metformin may improve menstrual cyclicity and fertility in women with the PCOS, and insulin-sensitizing agents provide a rational approach to the treatment of the metabolic and endocrine abnormalities in PCOS women.
Fertility and SterilityMetformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome
294 Citations1998Laure Morin‐Papunen, Riitta Koivunen +2 more
Metformin therapy is well tolerated by the majority of patients and may be clinically useful, especially in obese patients with PCOS and menstrual disturbances, particularly in women with menstrual disturbances.
Diabetes CareInsulin Resistance, Hyperinsulinemia, Hypertriglyceridemia, and Hypertension: Parallels Between Human Disease and Rodent Models
288 Citations1991Gerald M. Reaven
There is evidence that the changes in glucose, insulin, and lipoprotein metabolism may play a role in the etiology and/or clinical course of patients with high blood pressure and an effort is made to marshal the evidence in support of the latter alternative.
MetabolismMetformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome
252 Citations1997Elsy Velázquez, Soaira G. Mendoza +2 more
Metformin decreases Izero in hyperinsulinemic PCOS patients, reverses the hyperinsulinemia-driven endocrinopathy, decreases PAI-1, and decreases Lp(a), and should thus reduce the increased risk of atherothrombosis in PCOS.
New England Journal of MedicineLow Urinary<i>chiro</i>-Inositol Excretion in Non-Insulin-Dependent Diabetes Mellitus
219 Citations1990Allison S. Kennington, Cynthia R. Hill +7 more
NIDDM is associated with decreased chiro-inositol excretion and decreased chira-Inositol content in muscle, and these abnormalities seem to reflect the presence of insulin resistance in NIDDM.
Proceedings of the National Academy of Scienceschiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects.
168 Citations1993I. Asplin, Gail Galasko +1 more
Insulin mediator bioactivity was isolated from hemodialysate, urine, and autopsy muscle of type II diabetic subjects and nondiabetic control subjects to investigate their bioactivity and chiro-inositol content.
Hormone and Metabolic ResearchAnthropometric Variables and Metabolism in Polycystic Ovarian Disease
145 Citations1989M Rebuffé-Scrive, Göran Cullberg +3 more
It was concluded that body fat distribution is more closely related to hypertension and metabolic derangements than total fat mass in the PCO syndrome.
The American Journal of MedicineObesity, lipids, cardiovascular risk, and androgen excess
142 Citations1995Robert A. Wild
It is important that primary care providers begin to recognize these androgen disorders as a clue to the existence of a complex, lifelong pattern potentially placing women at risk for premature morbidity and mortality and initiate preventive treatment before irreversible thresholds are crossed.
RadiologyPolycystic ovarian disease: US features in 104 patients.
140 Citations1987Hsu‐Chong Yeh, Walter Futterweit +1 more
The most important feature of PCOD on US scans is the bilaterally increased numbers of developing follicles, usually more than five in each ovary.
EndocrinologyChiroinositol deficiency and insulin resistance. II. Acute effects of D-chiroinositol administration in streptozotocin-diabetic rats, normal rats given a glucose load, and spontaneously insulin-resistant rhesus monkeys.
106 Citations1993Heidi K. Ortmeyer, Laura C. Huang +3 more
D-CI administration, therefore, lowered elevated plasma glucose in streptozotocin-treated hyperglycemic rats, normal rats given a glucose load, and spontaneously insulin-resistant monkeys with or without noninsulin-dependent diabetes mellitus.
Journal of Internal MedicineThe android woman – a risky condition
105 Citations1996Per Björntorp
Women in the lowest quintiles of levels of sex‐hormone‐binding globulin – an indicator inversely related to active androgens – are at risk of developing hypertension, non‐insulin‐dependent diabetes mellitus and cardiovascular mortality.
American Journal of Obstetrics and GynecologyLipid and apolipoprotein abnormalities in hirsute women
105 Citations1992Robert A. Wild, Petar Alaupovic +1 more
Lipid and apolipoprotein abnormalities in these hirsute women seem to be associated more with insulin resistance than with endogenous androgens or estrogens.
Journal of Biological ChemistryIn vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues.
94 Citations1992Yunbae Pak, Laura C. Huang +2 more
Acid hydrolysates of combined inositol-containing phospholipids contain significant labeled chiroinositol, which was highest in blood (60.4%) followed by muscle (7.7%) and liver (2.2%), and glucuronate, the product of myoinositol oxidation, was unlabeled.
EndocrinologyChiroinositol deficiency and insulin resistance. I. Urinary excretion rate of chiroinositol is directly associated with insulin resistance in spontaneously diabetic rhesus monkeys.
89 Citations1993Heidi K. Ortmeyer, Noni L. Bodkin +3 more
The urinary CI excretion rate may be a biochemical indicator of both in vivo and in vitro insulin resistance and a noninvasive diagnostic tool with potential for the identification of those individuals at risk for NIDDM and other related diseases with insulin resistance.
Diabetes CareUrinary <i>chiro</i>-Inositol Excretion is an Index Marker of Insulin Sensitivity in Japanese Type II Diabetes
86 Citations1994Susumu Suzuki, Hiromasa Kawasaki +12 more
Urinary chiro-inositol excretion might be useful as a metabolic index of insulin sensitivity in type II diabetic patients and a direct link to insulin sensitivity and SG in humans is found.
Diabetic MedicineInsulin Insensitivity in Offspring of Parents with Type 2 Diabetes Mellitus
69 Citations1990L.‐T. Ho, Zer-Yuang Chang +5 more
The results support the view that resistance to insulin‐stimulated glucose uptake is present in offspring of diabetic parents.
Proceedings of the National Academy of SciencesInsulin stimulates the biosynthesis of chiro-inositol-containing phospholipids in a rat fibroblast line expressing the human insulin receptor.
46 Citations1993Yunbae Pak, Charles R. Paule +3 more
Findings indicate that insulin stimulates de novo synthesis of chiro-inositol-containing phospholipids at the inositolospholipid level.
EndocrinologyChiroinositol deficiency and insulin resistance. I. Urinary excretion rate of chiroinositol is directly associated with insulin resistance in spontaneously diabetic rhesus monkeys
33 Citations1993Heidi K. Ortmeyer